Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Short-Term Debt issuances (2012 - 2021)

Updated

Dr Reddys Laboratories' Short-Term Debt issuances came in at $229.51 million for FY2026 (year ended Mar 31, 2026), down 20.8% from $289.75 million in FY2025.

Analysis

Dr Reddys Laboratories (RDY) Short-Term Debt issuances (2012 - 2021) Analysis & Trends

Going back to FY2009, Dr Reddys Laboratories' Short-Term Debt issuances data covers 8 fiscal years.

  • Short-Term Debt issuances carries a five-year compound annual growth rate of 20.2% (FY2021 to FY2026).
  • The five-year range for annual Short-Term Debt issuances is $46 million (FY2022) to $289.75 million (FY2025).
  • Per Business Quant, earlier fiscal years put Short-Term Debt issuances at $289.75 million in FY2025 (+336.7%), $66.36 million in FY2024 and $46 million in FY2022 (-49.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 2.28 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 36.10 Mn
Jun 30, 2020 73.87 Mn
Jun 30, 2013 4.05 Bn
Jun 30, 2012 1.25 Bn
API Access

Dr Reddys Laboratories Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=RDY&period=max&api_key=YOUR_API_KEY